Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03583086
Recruitment Status : Recruiting
First Posted : July 11, 2018
Last Update Posted : September 18, 2020
Sponsor:
Collaborators:
Bristol-Myers Squibb
Xcovery Holdings, INC
Information provided by (Responsible Party):
Kathryn Beckermann, Vanderbilt-Ingram Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 2023
Estimated Study Completion Date : July 2024